Heart and Lung Function Monitoring System

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Heart DiseasesLung Diseases
Interventions
DEVICE

Integrated CardioRespiratory System

Participants will be asked to wear a non-invasive band on their upper abdomen while laying down. This band includes acoustic sensors. A remote monitoring device will continuously monitor and record heart rate and lung volumes and function.

DEVICE

Transthoracic Echocardiography (TTE)

Participants will undergo a TTE examination. During the TTE, a technician obtains views of the heart by moving a small instrument called a transducer to different locations on the chest or abdominal wall.

DEVICE

Electrocardiography

Participants will also have ECG monitoring as part of the TTE exam, which records the electrical activity of the heart using electrodes placed on the body.

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02168049 - Heart and Lung Function Monitoring System | Biotech Hunter | Biotech Hunter